Contents
Anti-Cancer Agents in Medicinal Chemistry, Volume 11 - Number 5
Editorial [Hot Topic: Emerging Therapeutic Targets and Agents for Pancreatic Cancer Therapy (Guest Editor: Dr. Felix Ruckert)]
, 11(5): 408 - 410Susanne Sebens and Holger Kalthoff
DOI: 10.2174/187152011795677418
An Update on Molecular Research of Pancreatic Adenocarcinoma
, 11(5): 411 - 417Christian Krautz, Felix Ruckert, Hans-Detlev Saeger, Christian Pilarsky and Robert Grutzmann
DOI: 10.2174/187152011795677409
Combination Therapy for the Treatment of Pancreatic Cancer
, 11(5): 418 - 426William Greenhalf and Amy Thomas
DOI: 10.2174/187152011795677391
Insulin-Like Growth Factor Signaling as a Therapeutic Target in Pancreatic Cancer
, 11(5): 427 - 433Simon Rieder, Christoph W. Michalski, Helmut Friess and > Kleeff
DOI: 10.2174/187152011795677454
Aptamers: Potential Applications to Pancreatic Cancer Therapy
, 11(5): 434 - 441Kristy L. Rialon and Rebekah R. White
DOI: 10.2174/187152011795677472
Genes Associated with Epithelial-Mesenchymal Transition: Possible Therapeutic Targets in Ductal Pancreatic Adenocarcinoma?
, 11(5): 448 - 454Hubert G. Hotz, Birgit Hotz and Heinz-Johannes Buhr
DOI: 10.2174/187152011795677436
Targeting Phosphoinositide 3-Kinase Pathways in Pancreatic Cancer – from Molecular Signalling to Clinical Trials
, 11(5): 455 - 463Marco Falasca, Federico Selvaggi, Richard Buus, Sara Sulpizio and Charlotte E. Edling
DOI: 10.2174/187152011795677382
Anti-Angiogenic Agents in Pancreatic Cancer: A Review
, 11(5): 464 - 469Murwarid M. Assifi and Oscar J. Hines
DOI: 10.2174/187152011795677463
Pancreatic Cancer in Obesity: Epidemiology, Clinical Observations, and Basic Mechanisms
, 11(5): 470 - 478Nicholas J. Zyromski and Patrick B. White
DOI: 10.2174/187152011795677445
Resveratrol and Its Analogues: Promising Antitumor Agents
, 11(5): 479 - 490Hai-Liang Zhu
DOI: 10.2174/187152011795677427
Webmaster Contact: info@benthamscience.org